Article

Dass, Crispin R, Ek, Eugene T. H and Choong, Peter F. M (2008) PEDF as an emerging therapeutic candidate for osteosarcoma. Current Cancer Drug Targets, 8 (8). pp. 683-690. ISSN 1568-0096

Dass, Crispin R, Ek, Eugene T. H and Choong, Peter F. M (2007) Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing. Journal of Cancer Research and Clinical Oncology, 133 (3). pp. 193-198. ISSN 0171-5216

Ek, Eugene T. H, Dass, Crispin R, Contreras, Karla G and Choong, Peter F. M (2007) Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clinical and Experimental Metastasis, 24 (2). pp. 93-106. ISSN 0262-0898

Ek, Eugene T. H, Dass, Crispin R, Contreras, Karla G and Choong, Peter F. M (2007) Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Therapy, 14 (7). pp. 616-626. ISSN 0929-1903

Ek, Eugene T. H, Dass, Crispin R, Contreras, Karla G and Choong, Peter F. M (2007) PEDF-Derived Synthetic Peptides Exhibit Antitumor Activity in an Orthotopic Model of Human Osteosarcoma. Journal of Orthopaedic Research, 25 (12). pp. 1671-1680. ISSN 0736-0266

Ek, Eugene T. H, Dass, Crispin R and Choong, Peter F. M (2006) Commonly used mouse models of osteosarcoma. Critical Reviews in Oncology Hematology, 60 (1). pp. 1-8. ISSN 1040-8428

Ek, Eugene T. H, Dass, Crispin R and Choong, Peter F. M (2006) Pigment epithelium-derived factor: a multimodal tumor inhibitor. Molecular Cancer Therapeutics , 5 (7). pp. 1641-1646. ISSN 1535-7163

Dass, Crispin R, Ek, Eugene T. H, Contreras, Karla G and Choong, Peter F. M (2006) A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clinical and Experimental Metastasis , 23 (7-8). pp. 367-380. ISSN 0262-0898

Ek, Eugene T. H, Dass, Crispin R and Choong, Peter F. M (2006) PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends in Molecular Medicine, 12 (10). pp. 497-502. ISSN 1471-4914